AISA Pharma Gets FDA Orphan Drug Status For AISA-021 In Systemic Sclerosis
09 Sep 2024 //
PR NEWSWIRE
AISA Pharma Announces Start of Ph2b Profervia® Study for Raynaud`s Phenomenon
21 Jun 2023 //
PR NEWSWIRE
AISA Pharma Announces NIH-NINDS Award to investigate Profervia
03 Apr 2023 //
PR NEWSWIRE